Bank of America’s PaxMedica, Inc. Common Stock PXMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
– Sell
-29
Closed -$143 – 8395
2023
Q3
$143 Hold
29
– – ﹤0.01% 7439
2023
Q2
$393 Sell
29
-219
-88% -$5.37K ﹤0.01% 7341
2023
Q1
$8.04K Sell
248
-608
-71% -$24.4K ﹤0.01% 6970
2022
Q4
$29.5K Buy
+856
New +$30.6K ﹤0.01% 6631

Other funds holding PXMD

Bank of America's PXMD Position: Q4 2023 in Review

Bank of America sold out of PaxMedica, Inc. Common Stock (PXMD) in Q4 2023, closing a stake of 29 shares — an estimated $143 sold.

Bank of America first reported a position in PXMD in Q4 2022 and held it in 4 quarters. The position peaked at $29.5K in Q4 2022. 9 funds tracked by Wall St. Rank hold PXMD as of Q4 2023.

  • Bank of America reported no remaining PaxMedica, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • Bank of America sold 29 PaxMedica, Inc. Common Stock shares in Q4 2023, an estimated $143.
  • Bank of America first reported a position in PaxMedica, Inc. Common Stock in Q4 2022 and held it in 4 quarters.
  • Bank of America's PaxMedica, Inc. Common Stock position peaked at $29.5K in Q4 2022.
  • 9 funds tracked by Wall St. Rank held PaxMedica, Inc. Common Stock as of Q4 2023.

Based on Bank of America's 13F filing for Q4 2023, filed 14 Feb 2024.